HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Glycogen storage disease type Ia — Clinical Guidelines

Overview

Glycogen storage disease type Ia (GSD Ia) is characterized by a deficiency in glucose-6-phosphatase, leading to impaired glucose homeostasis, accumulation of glycogen in tissues, and often associated complications such as hyperlipidemia, lactic acidosis, and renal dysfunction 1 5 8.

Diagnosis

Clinical Presentation: Recurrent episodes of pain, swelling, and fever, particularly in joints; hepatomegaly; hypoglycemia; hyperlipidemia; lactic acidosis 1 5.

Laboratory Tests: Elevated uric acid levels, hyperlipidemia, low fasting blood glucose, elevated lactate levels 1 5.

Histopathology: Significant glycogen accumulation in liver biopsy 1.

Genetic Testing: Identification of SLC37A4 gene mutations 2.

Management

Dietary Management: Frequent small carbohydrate-rich meals to maintain blood glucose levels 1 5.

Supplementation: Potentially supplemental glucose or dextrose solutions to manage hypoglycemia 1.

Monitoring: Regular monitoring of renal function due to risk of focal segmental glomerulosclerosis 8.

Liver Transplantation: Indicated in cases of severe hepatic complications or failure 6.

Special Populations

Pediatrics: Early recognition crucial due to childhood onset of symptoms 1 5.

Comorbidities: Hyperuricemia can manifest as gout, necessitating management of uric acid levels 3 5 9.

Key Recommendations

Early Diagnosis and Dietary Management: Implement frequent carbohydrate intake to stabilize blood glucose levels in patients with GSD Ia (Evidence: Moderate 1 5).

Regular Monitoring of Renal Function: Screen for and manage renal complications, particularly focal segmental glomerulosclerosis, due to the risk of progressive renal damage (Evidence: Moderate 8).

Consider Liver Transplantation: Evaluate liver transplantation for patients with severe hepatic complications or failure (Evidence: Weak 6).

References

1 Dan L, Song X, Yu H. A case of glycogen storage disease type . Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2023. link 2 Xu Q, Tang H, Duan L, Zuo X, Shi X, Li Y et al.. A novel SLC37A4 missense mutation in GSD-Ib without hepatomegaly causes enhanced leukocytes endoplasmic reticulum stress and apoptosis. Molecular genetics & genomic medicine 2021. link 3 Üsküdar Cansu D, Erdoğan B, Korkmaz C. Can hyperuricemia predict glycogen storage disease (McArdle's disease) in rheumatology practice? (Myogenic hyperuricemia). Clinical rheumatology 2019. link 4 Zhang W, Bao CD, Gu YY, Ye S. Glycogen storage disease manifested as gout and myopathy: three case reports and literature review. Clinical rheumatology 2008. link 5 Carvès C, Duquenoy A, Toutain F, Trioche P, Zarnitski C, Le Roux P et al.. Gouty tendinitis revealing glycogen storage disease Type Ia in two adolescents. Joint bone spine 2003. link00020-4) 6 Faivre L, Houssin D, Valayer J, Brouard J, Hadchouel M, Bernard O. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia. Journal of inherited metabolic disease 1999. link 7 Dhawan A, Tan KC, Portmann B, Mowat AP. Glycogenosis type IV: liver transplant at 12 years. Archives of disease in childhood 1994. link 8 Reitsma-Bierens WC. Renal complications in glycogen storage disease type I. European journal of pediatrics 1993. link 9 Jinnai K, Kono N, Yamamoto Y, Kanda F, Ohno S, Tsutsumi M et al.. Glycogenosis type V (McArdle's disease) with hyperuricemia. A case report and clinical investigation. European neurology 1993. link 10 Kawaguchi Y, Shirasawa K, Yotsumoto S, Nagahara S. Type III glycogenosis with deposition of urate and amyloid. Acta pathologica japonica 1980. link 11 Casson H. Anaesthesia for portocaval bypass in patients with metabolic diseases. British journal of anaesthesia 1975. link 12 Stamm WE, Webb DI. Partial deficiency of hepatic glucose-6-phosphatase in an adult patient. Archives of internal medicine 1975. link

Glycogen storage disease type Ia